Rare Diseases Weekly Roundup
Weekly Roundup: October 11, 2018
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:07:49
- Mas informaciones
Informações:
Sinopsis
The P4A team analyze Novartis' deal with Celluar Biomedicine Group to supply the CAR-T therapy Kymriah and the successes and failures of the reimbursement of Vertex's cystic fibrosis drug, Orkambi. Presenter: Max Rex Contributor: Nader Murad, Senior Analyst
